Skip to main content
. 2024 Aug 9;27(8):pyae031. doi: 10.1093/ijnp/pyae031

Table 2.

Self-reported Substance Use (Mean ± SE)a

Control Methamphetamine use disorder
Smoking
N = 6
Non-smoking
N = 8
Smoking
N = 8
Non-smoking
N = 6
Methamphetamine use
 Duration (y) 6.52 ± 2.45 8.28 ± 3.13
 Average daily use (g/d) 2.6 ± 1.7 1.3 ± 0.4
 Days used in last 30 d 21.6 ± 4.6 9.7 ± 3.2
 Duration of abstinence (d) 38.9 ± 6.0 45.2 ± 5.8
 Route of administration
  Smoking, n (%) 7 (87.5) 5 (83.3)
  Intravenous injection, n (%) 0 (0) 2 (33.3)
  Sniff/snort, n (%) 3 (37.5) 5 (83.3)
Tobacco use
 Days used in last 30 d 17.5 ± 4.3 26.3 ± 2.1
 Cigarettes per day 7.3 ± 2.9 7.1 ± 2.0
 Duration of abstinence (h) 1063.6 ± 40.7 18.8 ± 1.0
 Nicotine withdrawal (Shiffman-
Jarvik average score)
3.3 ± 0.7 3.2 ± 0.5
 Fagerström (FTND) score 2.8 ± 1.4 2.4 ± 0.8
Cannabis use
 Number of participants, n (%) 2 (33.3) 1 (12.5) 3 (37.5) 2 (33.3)
 Days used in last 30 d 12 ± 8 5 13.0 ± 8.6 1.5 ± 0.5
Alcohol use
 Number of participants, n (%) 6 (100) 4 (50) 3 (37.5) 2 (33.3)
 Days used in last 30 d 7.7 ± 2.2 4.2 ± 2.1 10.3 ± 6.6 9.5 ± 5.5

Abbreviations: FTND, Fagerström test for nicotine dependence.

a No significant differences in tobacco, cannabis, or alcohol use.